ArticleEBioMedicine2019

PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis.

Cristian Rodriguez-Aguayo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.